§ EQUITY
USDCUE
CUE BIOPHARMA INC
USD
§ 01 · PRICE
Price action
1D5D1M6MYTD1YMAX
§ 03 · SIGNAL STACK · WHAT THE INPUTS SAY
§ 05 · WHO OWNS IT
Top institutional holders
| Fund | Shares | % port | Δ Q/Q |
|---|---|---|---|
| Bleichroeder LP | 6.8M | 0.3% | ±0% |
| GC Wealth Management RIA, LLC | 4.6M | 0.0% | ±0% |
| VANGUARD CAPITAL MANAGEMENT LLC | 2.5M | 0.0% | n/a |
| VANGUARD CAPITAL MANAGEMENT LLC | 2.5M | 0.0% | n/a |
| Lion Point Capital, LP | 2.2M | 3.0% | ±0% |
| Geode Capital Management | 919K | 0.0% | +33% |
◇ AC INTELLIGENCE
Top institutional owners for CUE as of the most recent 13F reporting period (Q1 2026 · Period ended Mar 31). Δ Q/Q reflects share-count change vs. the prior filing — positive green means adding, negative red means trimming. Cross-reference with the ownership-mix bars below to see which strategy cohort is driving the flow.
§ 06 · WHO OWNS IT · BY STRATEGY
OTHER88.1% · 40 holders
PASSIVE / INDEX6.3% · 2 holders
DEALER / BANK4.3% · 12 holders
SYSTEMATIC / QUANT0.9% · 1 holder
INCOME / DEFENSIVE0.3% · 1 holder
TACTICAL / MACRO0.1% · 1 holder
◇ AC INTELLIGENCE
Ownership mix by behavioral cohort. Top bars indicate which style of capital dominates the float — passive indexing, quality compounders, dealer/bank, systematic quant, etc. Big quality-compounder share means concentrated active conviction; heavy passive share means flows are dictated by index rebalances, not fundamentals.
§ 07 · INSIDER ACTIVITY · LAST 180 DAYS
NO INSIDER FILINGS
◇ AC INTELLIGENCE
No Form 4 filings on record for CUE in the last 180 days.